top of page

Recombinant Human C-X-C Motif Chemokine 2/CXCL2
Recombinant Human C-X-C Motif Chemokine 2 is produced by our E.coli expression system and the target gene encoding Thr39-Asn107 is expressed. Bon Opus Cat. #C096

Recombinant Human C-X-C Motif Chemokine 2/CXCL2

SKU: C096-10ug
$158.00Price
Quantity
[{"key":"C096-50ug","value":"Backorder"},{"key":"C096-500ug","value":"Backorder"},{"key":"C096-10ug","value":"Backorder"}]

Contact Us

Phone: 800-943-6396 ext#1

Email: orders@bonopusbio.com

Distributors

Shipping Information

$48 Standard Overnight flat rate for products shipped in room temperature within the United States.

 

Additional $27 Ice Packs shipment fee is required for liquid proteins.

 

Please contact us to order for  international shipments.

Endotoxin
Less than 0.1 ng/ug (1 EU/ug) as determined by LAL test.
Accession Number
P19875
Species
Human
Expression System
E.coli
Target Sequence
Thr39-Asn107
Tag
tag free
Formulation
Lyophilized from a 0.2 um filtered solution of 20mM Tris-HCl,150mM NaCl,pH8.0.
Packaging
Ambient
Background
Chemokine Ligand 2 (CXCL2) is a small secreted cytokine which belongs to the CXC chemokine family. It is secreted by monocytes and macrophages and chemotactic for polymorphonuclear leukocytes and hematopoietic stem cells. CXCL2 mobilizes cells by interacting with a cell surface chemokine receptor called CXCR2. It has been known to regulate immune functions mainly by chemo-attracting neutrophils. It is produced by activated monocytes and neutrophils and expressed at sites of inflammation. It is a hematoregulatory chemokine, which suppresses hematopoietic progenitor cell proliferation. It can be induced by receptor activator of NF-kappaB ligand, the osteoclast (OC) differentiation factor, through JNK and NF-kappaB signaling pathways in OC precursor cells. CXCL2 in turn enhanced the proliferation of OC precursor cells of bone marrow-derived macrophages (BMMs) through the activation of ERK. Knockdown of CXCL2 inhibited both the proliferation of and the ERK activation in BMMs. During osteoclastogenesis CXCL2 stimulated the adhesion and the migration of BMMs. CXCL2 is a novel therapeutic target for inflammatory bone destructive diseases.
Purity
Greater than 95% as determined by reducing SDS-PAGE.
C-X-C Motif Chemokine 2; Growth-Regulated Protein Beta; Gro-Beta; Macrophage Inflammatory Protein 2-Alpha; MIP2-Alpha; CXCL2; GRO2; GROB; MIP2A; SCYB2
Alternative Names
Be the first to submit a citation to get publication rewards
Citation
NA
Activity
bottom of page